[個々の患者の確率:不確実性に関する誤解と医療意思決定における統計モデルの役割]

Harm-Jan de Grooth^1,2, Ewout W Steyerberg³

¹UMC Utrecht, Utrecht. Afd. Intensive Care.

Nederlands tijdschrift voor geneeskunde

|February 20, 2026

まとめ

患者の確率の解釈は難しい. この研究は,個々の確率は客観的に真実ではないが,合理的で条件付きの推定であり,臨床的専門知識と経験的データが必要であり,正確な患者の結果予測を行う必要があることを明らかにしている.

科学分野:

医療統計医療統計について
臨床的意思決定について
確率に関する哲学.

背景:

患者の個々の確率 (例えば,5%のリスク) を解釈することは,概念的に難しい.
集団における統計的確率の共通解釈は,ユニークな個体に対して疑問視される.
個々の確率の客観的真実や恣意性に関する誤解が存在します.

研究の目的:

個々の患者の確率に関する誤解を解決するために.
確率解釈に関する哲学的,統計学的視点を探求する.
臨床的文脈における合理的で条件付きの確率推定のための枠組みを提案する.

主な方法:

確率に関する哲学的,統計学的視点の探求.
グループ統計と対比した個々の予測の性質の分析.
確率推定における参照クラスの役割に重点を置く.

主要な成果:

個々の確率は客観的に真ではないが,合理的で条件付きの推定値である.
不確実な患者のアウトカムの予測は,臨床専門家の批判的な評価を必要とします.
臨床的判断は,経験的データによって知られ,制約されなければならない.

結論:

確率の限界をより明確に理解することで,AIの使用,臨床推論,患者とのコミュニケーションが改善されます.
合理的確率の推定は条件付きであり,文脈に依存している.
統計モデルと臨床専門知識の統合は,信頼性の高い患者のアウトカム予測に不可欠です.

さらに関連する動画

04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K

09:07

Experimental Research Examining How People Can Cope with Uncertainty Through Soft Haptic Sensations

Published on: September 16, 2015

9.5K

関連する概念動画

00:59

Uncertainty: Overview

1.8K

In analytical chemistry, we often perform repetitive measurements to detect and minimize inaccuracies caused by both determinate and indeterminate errors. Despite the cares we take, the presence of random errors means that repeated measurements almost never have exactly the same magnitude. The collective difference between these measurements - observed values - and the estimated or expected value is called uncertainty. Uncertainty is conventionally written after the estimated or expected value.

1.8K

01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...

01:20

Biostatistics: Overview

927

Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...

927

01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

290

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...

290

01:26

Pharmacokinetic Models: Comparison and Selection Criterion

393

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

393

01:20

Pharmacokinetic Models: Overview

2.2K

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...